Legend Biotech (LEGN) shares were down 4.6% in Friday trading after UBS downgraded the company's stock to neutral from buy and adjusted its price target to $28 from $49.
Trading volume stood at over 984,600 shares compared with a daily average of 2.6 million.
Price: $22.45, Change: $-1.08, Percent Change: -4.59%
Business First Bancshares (BFST) reported core Q2 earnings late Thursday of $0.71 per diluted share, up from $0.66 a year earlier.Analysts polled by FactSet expected $0.70.Revenue in the three months ended June 30, expressed as net interest income plus total other income, rose to $91.8 million from $81.5 million.Four analysts expected $91.3 million.The company's shares fell 3.3% in after-hours trading.
RingCentral (RNG) reported Q2 non-GAAP net income late Thursday of $1.22 per diluted share, up from $1.06 a year earlier.Analysts polled by FactSet expected $1.16.Revenue in the three months ended June 30 rose to $657 million from $620 million a year earlier.Analysts expected $650.5 million.RingCentral expects Q3 non-GAAP EPS of $1.25 to $1.30 on revenue of $664 million to $670 million.Analysts expect EPS of $1.25 on revenue of $663.2 million.The company raised full-year non-GAAP EPS guidance to the range of $4.96 to $5.10 on revenue of $2.635 billion to $2.646 billion. The previous forecast was EPS of $4.85 to $5.01 on revenue of $2.62 billion to $2.64 billion.Analysts expect EPS of $4.92 on revenue of $2.63 billion.RingCentral shares rose 1.2% in after-hours trading.
Robert Half (RHI) reported Q2 net income late Thursday of $0.26 per share, down from $0.41 a year earlier.Analysts polled by FactSet expected $0.26.Revenue in the three months ended June 30 fell to $1.34 billion from $1.37 billion a year earlier.Analysts expected $1.32 billion.The company's shares fell 5.3% in after-hours trading.